We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

AMOT:TASEAmot Investments Ltd. Analysis

Data as of 2026-03-17 - not real-time

€4.02

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Amotiv Limited is trading well below its longer‑term moving averages, with the price sitting under both the short‑term and medium‑term trends, indicating a bearish technical backdrop. The RSI is deep in oversold territory, suggesting a potential short‑term bounce, yet the MACD remains bearish, reinforcing downward momentum. The stock carries a high dividend yield that appears attractive, but the company is posting negative earnings and a modest revenue growth rate, raising questions about the sustainability of payouts. Valuation metrics point to a sizable gap between the current price and the discounted cash‑flow estimate, implying that the market may be undervaluing the business at present.
Despite a volatile price history and a beta above one, the firm benefits from a diversified geographic footprint across Australia, New Zealand, Asia and the United States, which can cushion regional downturns. However, the sizable debt load relative to equity and a negative profit margin amplify financial risk. Investors should weigh the appealing dividend against the earnings weakness and consider the stock as a potential value play if they are comfortable with the elevated risk profile.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • price below short‑term moving averages
  • oversold RSI indicating limited upside
  • persistent bearish MACD signal

Medium Term

1–3 years
Positive
Model confidence: 6/10

Key Factors

  • valuation gap versus discounted cash‑flow estimate
  • high dividend yield that could attract income investors
  • potential for earnings improvement as cost structure stabilises

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • underlying asset value exceeds market price
  • diversified geographic exposure supporting resilience
  • opportunity for balance‑sheet deleveraging and profitability turn‑around

Key Metrics & Analysis

Financial Health

Revenue Growth3.30%
Profit Margin-9.20%
ROE-11.31%
ROA6.27%
Debt/Equity78.20
P/B Ratio1.2
Op. Cash Flow€168.8M
Free Cash Flow€98.3M

Technical Analysis

TrendBearish
RSI26.3
Support€4.00
Resistance€4.90
MA 20€4.42
MA 50€4.74
MA 200€4.85
MACDBearish
VolumeStable
Fear & Greed Index80.7

Valuation

Fair Value€7.41
GradeUndervalued
TypeValue
Dividend Yield6.11%

Risk Assessment

Beta1.28
Volatility32.39%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskHigh
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.